{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:41:36Z","timestamp":1770698496199,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1016\/s0952-7915(97)80052-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:32:55Z","timestamp":1027593175000},"page":"702-708","source":"Crossref","is-referenced-by-count":81,"title":["Prospects for adoptive T cell therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Cassian","family":"Yee","sequence":"first","affiliation":[]},{"given":"Stanley R","family":"Riddell","sequence":"additional","affiliation":[]},{"given":"Philip D","family":"Greenberg","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(97)80052-0_BIB1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/86.15.1159","article-title":"Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 [see comments]","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB3","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"Van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.179.3.921","article-title":"Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes","volume":"179","author":"Gaugler","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.183.3.1173","article-title":"A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene","volume":"183","author":"Guilloux","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.7652577","article-title":"A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma","volume":"269","author":"Wolfel","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.183.3.1185","article-title":"A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes","volume":"183","author":"Robbins","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.178.2.489","article-title":"The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"178","author":"Brichard","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.180.1.35","article-title":"A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]","volume":"180","author":"Coulie","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB10","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into the tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB11","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","article-title":"Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.183.3.1131","article-title":"Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen","volume":"183","author":"Wang","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB13","first-page":"3124","article-title":"Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy","volume":"54","author":"Robbins","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(96)00007-5","article-title":"Detection and quantification of blood-derived CD8* T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens","volume":"191","author":"Herr","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.180.1.347","article-title":"Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes","volume":"180","author":"Kawakami","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ijc.2910640505","article-title":"Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1\/Melan-A, gp100 and tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients","volume":"64","author":"Spagnoli","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB17_1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.184.2.647","article-title":"Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1(27\u201335)","volume":"184","author":"Loftus","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB18_1","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.157.9.4079","article-title":"Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus","volume":"157","author":"Yee","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB19","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.4049\/jimmunol.157.11.5027","article-title":"Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17\/gp100","volume":"157","author":"Skipper","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1523-1747.ep12298177","article-title":"The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17\/gp100","volume":"107","author":"Zarour","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB21","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.154.8.3961","article-title":"Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression","volume":"154","author":"Kawakami","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB22_1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.158.4.1796","article-title":"Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells","volume":"158","author":"Tsai","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB24","first-page":"3223","article-title":"Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melonoma cell lines and in human melanocytic lesions","volume":"57","author":"de Vries","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB25","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.92.18.8125","article-title":"Immunophenotyping of melanomas for tyrosinase: implications for vaccine development","volume":"92","author":"Chen","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.178.3.933","article-title":"A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target","volume":"178","author":"Seung","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.184.2.441","article-title":"Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens","volume":"184","author":"Dudley","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/eji.1830250206","article-title":"Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistant with immune selection","volume":"25","author":"Lehmann","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB29_1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0","article-title":"Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma","volume":"71","author":"Jager","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB30_1","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1073\/pnas.93.12.5915","article-title":"Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas","volume":"93","author":"Chen","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB31_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4049\/jimmunol.156.1.208","article-title":"Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma","volume":"156","author":"Anichini","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB32","first-page":"179","article-title":"A monoclonal antibody specific for cells of the melanocyte lineage","volume":"130","author":"Vannegoor","year":"1988","journal-title":"Am J Path"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.177.4.989","article-title":"Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients","volume":"177","author":"Arichini","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/intimm\/8.5.799","article-title":"Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease","volume":"8","author":"Sugita","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB35","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.177.6.1681","article-title":"An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retrovival tumor antigen in normal lymphoid tissues","volume":"177","author":"Hu","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB36_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.185.3.453","article-title":"Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma","volume":"185","author":"Bloom","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB37","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1073\/pnas.91.6.2105","article-title":"Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes","volume":"91","author":"Celis","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB38_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1084\/jem.184.2.485","article-title":"Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL","volume":"184","author":"Alexander","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB39_1","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1073\/pnas.93.9.4102","article-title":"Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy","volume":"93","author":"Alexander","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0161-5890(94)90158-9","article-title":"Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles","volume":"31","author":"Celis","year":"1994","journal-title":"Mol Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB41","first-page":"4972","article-title":"Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides","volume":"55","author":"Salgaller","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0161-5890(95)00037-F","article-title":"In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides","volume":"32","author":"Wentworth","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB43","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.4049\/jimmunol.154.5.2257","article-title":"Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1","volume":"154","author":"Rivoltini","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB44","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.137.9.3036","article-title":"Stepwise immunologic selection of antigenic variants during tumor growth","volume":"137","author":"Urban","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.150.2.438","article-title":"Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules","volume":"150","author":"Rock","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nm0595-481","article-title":"Gene gun and other non-viral approaches for cancer gene therapy","volume":"1","author":"Yang","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB48","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection","volume":"68","author":"Matloubian","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor [see comments]","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB50","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB51_1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1084\/jem.183.5.1965","article-title":"Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes","volume":"183","author":"Topalian","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB52","first-page":"17","article-title":"Infections in bone marrow transplantation","author":"Meyers","year":"1987"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB53","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation [see comments]","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB54_1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V89.6.1978","article-title":"Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease","volume":"89","author":"Sing","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB55_1","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.158.7.3325","article-title":"Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy","volume":"158","author":"Lee","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB56","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans \u2014 immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction [see comments]","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB57_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Henslop","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/hum.1992.3.3-319","article-title":"Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology","volume":"3","author":"Riddell","year":"1992","journal-title":"Hum Gene Ther"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB59_1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-tk gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0952-7915(97)80052-0_BIB60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/369333a0","article-title":"Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation","volume":"369","author":"Nelson","year":"1994","journal-title":"Nature"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791597800520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791597800520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T15:46:38Z","timestamp":1680795998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791597800520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["S0952791597800520"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(97)80052-0","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}